Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.26.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.26.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EW.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EW.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBPENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CL.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CL.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.366ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.366ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.441ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.441ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.416ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.416ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.263ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used